SCHEMBL28979459

SCHEMBL28979459

NC(=O)Oc1nc(-c2ccccc2Cl)cs1

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ATP4A P20648 3/20 0.55
▸ ATP4B P51164 3/20 0.55
▸ SMN1; SMN2 Q16637 2/20 0.50
▸ NPC1 O15118 2/20 0.50
▸ RAB9A P51151 2/20 0.50
▸ KDM4E B2RXH2 1/20 0.50
▸ GSTO1 P78417 1/20 0.49
▸ CYP19A1 P11511 1/20 0.47
▸ DHODH Q02127 6/20 0.45
▸ LMNA P02545 3/20 0.44
▸ KMT2A Q03164 1/20 0.44
▸ L3MBTL1 Q9Y468 1/20 0.43
▸ THRB P10828 1/20 0.42
▸ ALDH1A1 P00352 1/20 0.42
▸ CYP1A1 P04798 2/20 0.41
▸ CYP1A2 P05177 2/20 0.41
▸ CYP1B1 Q16678 2/20 0.41
▸ NAMPT P43490 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28979463 0.83 SMN1; SMN2 (0.52) SMN1; SMN2NPC1RAB9AKDM4ELMNA
SCHEMBL6660568 0.78 ATP4A (0.58) ATP4AATP4BSMN1; SMN2NPC1RAB9A
SCHEMBL27770666 0.77 CYP19A1 (0.53) ATP4AATP4BSMN1; SMN2NPC1RAB9A
SCHEMBL28979470 0.77 MKNK1 (0.45) ATP4AATP4BCYP19A1DHODH
SCHEMBL30377738 0.76 SMN1; SMN2 (0.45) ATP4AATP4BSMN1; SMN2NPC1RAB9A
SCHEMBL21747572 0.75 CCNK (0.43) ATP4AATP4BKDM4E
SCHEMBL30123146 0.73 HSD17B10 (0.62) ATP4AATP4BSMN1; SMN2NPC1RAB9A
SCHEMBL38240 0.73 HSD17B10 (0.62) ATP4AATP4BSMN1; SMN2NPC1RAB9A
SCHEMBL28467752 0.73 SMN1; SMN2 (0.62) ATP4AATP4BSMN1; SMN2NPC1RAB9A
SCHEMBL27791621 0.72 KDM4E (0.50) ATP4AATP4BSMN1; SMN2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115916776-A Collagen 1 translation inhibitors and methods of use thereof 艾尼莫生物科技公司 2023-04-04 — — CN disclosed
Send feedback